Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Hematol Malig Rep. 2006 Jun;1(2):114-21. doi: 10.1007/s11899-006-0022-7.

Clinical implications of gene expression profiling of acute myeloid leukemia.

Author information

1
Department of Haematology, Cardiff University, Heath Park, Wales, UK. millski@cardiff.ac.uk

Abstract

Since the first demonstration in 1999 that gene expression profiling could distinguish between different variants of acute leukemia, several studies have analyzed patients with acute myeloid leukemia on the basis of cytogenetics, morphologic subgroups, secondary mutations such as FLT3, prognosis, and therapeutic response. This review examines some of these data and attempts to discuss whether these analyses will have clinical applications in diagnosis, prediction of prognosis and response to therapy, disease classification, or individually targeted therapy. It is probable that all these areas will reach the clinical environment eventually, but in the short to medium term, microarrays will be involved only in diagnosis.

PMID:
20425341
DOI:
10.1007/s11899-006-0022-7
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center